Stock Market & Financial Investment News

News Breaks February 20, 2013 06:45 EDT JNJ, GILD Stocks with implied volatility movement; JNJ GILD Stocks with implied volatility movement; Johnson & Johnson (JNJ), Gilead (GILD) according to iVolatility. News For JNJ;GILD From The Last 14 Days Check below for free stories on JNJ;GILD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 07:54 EDT JNJ Johnson & Johnson drug business should maintain momentum, says Wells Fargo After attending J&J's bi-annual pharmaceutical business review, Wells Fargo believes that the revenue generated by four of the company's new drugs could double from 2012 to 2015. The firm thinks the company's pharmaceutical unit has one of the best growth outlooks in the sector, and it keeps an Outperform rating on the stock. 07:20 EDT GILD Celgene, Gilead, and Biogen could go much higher, says Bernstein Subscribe for More Information 06:28 EDT JNJ Johnson & Johnson price target raised to $94 from $88 at Leerink Subscribe for More Information May 23, 2013 10:27 EDT GILD Gilead has a conference call hosted by JPMorgan Subscribe for More Information 10:08 EDT JNJ On The Fly: Analyst Initiation Summary Subscribe for More Information 07:31 EDT JNJ Janssen expects to have more than 25 brand line extensions by 2017 Subscribe for More Information 06:29 EDT JNJ Johnson & Johnson coverage assumed with an Underperform at Credit Suisse Subscribe for More Information May 22, 2013 16:00 EDT JNJ Options Update; May 22, 2013 Subscribe for More Information May 21, 2013 16:51 EDT GILD Gilead's sofosbuvir gets EMA validation, now under assessment Subscribe for More Information 07:24 EDT JNJ Global Health Care to host a conference Subscribe for More Information May 20, 2013 07:34 EDT GILD UBS to host a conference Subscribe for More Information May 17, 2013 06:19 EDT JNJ J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports Subscribe for More Information May 16, 2013 11:50 EDT GILD Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 15, 2013 18:32 EDT GILD Gilead announces response data from Phase 2 study of Idelalisib Subscribe for More Information 16:51 EDT JNJ FDA approves Simponi to treat ulcerative colitis Subscribe for More Information May 13, 2013 09:39 EDT GILD Active equity option families trading Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR Sign up for a free trial to see the rest of the stories you've been missing.